Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome

clinical trial

Details

Instance of: Q30612
Start time: December 2001
End time: July 2012
Country: Q30
Main subject: Q179630, Q298230, Q2057356, Q183130, Q32811, Q505142, Q156103
P1132: 24
P1476: A Phase I/II Study of the Effect of Intravenous Anti-IL-5 (Mepolizumab) SB 240563 on the Outcome and Management of Hypereosinophilic Syndromes
P2899: 18
P4135: 65
P6099: Q5452194, Q42824440
P6153: Q5120231
P8363: Q9164018

Nothing in the MetaHistoryBook collection references this item yet.